This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Duke University. Active years: 2016-2022.
Company Filing History:
Years Active: 2016-2022
Title: Mark D Starr: Innovator in Cancer Treatment
Introduction
Mark D Starr is a prominent inventor based in Durham, NC (US), known for his significant contributions to cancer treatment methodologies. With a total of 4 patents, he has focused on developing innovative methods to predict and enhance the effectiveness of cancer therapies.
Latest Patents
Starr's latest patents include groundbreaking methods for predicting the responsiveness of cancer to VEGF targeting agents. One of his notable inventions involves obtaining a sample from a subject and determining the expression level of biomarkers such as VEGF-D and PlGF. By comparing these levels to reference standards, the methods can predict how well a cancer will respond to treatment. Additionally, he has developed methods for prognosing and treating pancreatic cancer, which involve detecting the expression levels of biomarkers like ANG-2, SDF-1, and VEGF-D to tailor treatment plans effectively.
Career Highlights
Mark D Starr is affiliated with Duke University, where he continues to advance research in cancer therapeutics. His work has been instrumental in providing new insights into how specific biomarkers can influence treatment outcomes for cancer patients.
Collaborations
Starr has collaborated with notable colleagues, including Herbert I Hurwitz and Andrew B Nixon, to further enhance the research and development of cancer treatment methodologies.
Conclusion
Mark D Starr's innovative work in cancer treatment exemplifies the critical role of inventors in advancing medical science. His patents not only contribute to the understanding of cancer therapies but also pave the way for more effective treatment strategies.